inhibited the increase in adipose tissue mass and lipids levels, including triacylglycerol or cholesterol, in high-fat diet-fed C57BL/6J mice. Thus, dietary polyphenols may show beneficial physiological effects on the modulation of lipid metabolism accompanying obesity.
We focused on the functionality of hop plant Humulus lupulus L. extracts, including high-molecular-weight procyanidins or xanthohumol in previous studies 5 . Xanthohumol is a prenylated chalconoid and non-hydrophilic flavonoid unlike other polyphenols. Several studies have reported that xanthohumol have bioactivities such as anticancer activity, anti-oxidant activity, and estrogenic activity 6 .
Dietary xanthohumol-rich hop extract XRHE, 18 xanthohumol suppressed the increase in body weight, mesenteric white adipose tissue, liver weight, and triacylglycerol levels in the plasma and liver through regulation of hepatic fatty acid metabolism and inhibition of intestinal fat absorption in Wistar rats fed a high-fat diet 7 . In addition, XRHE inhibited the intracellular fat droplets in and the differentiation of 3T3L1 cells by regulating adipogenic factors 8 .
Xanthohumol inhibits the development of obesity and hepatic steatosis through down-regulation of hepatic SREBP1 9 . Moreover, xanthohumol acts on farnesoid X receptor FXR , suppresses white adipose tissue weight, liver weight, plasma triacylglycerol, and glucose levels through the regulation of lipid and glucose metabolism 10 . Thus, the anti-obesity effect exerted by xanthohumol is expected; however, it is dependent on the experimental conditions and/or xanthohumol purity.
A major limitation of our studies is that the XRHE used contains unknown compounds in addition to xanthohumol, although these unknown compounds were not flavonoids. Therefore, we must use purified xanthohumol from XRHE to show the anti-obesity effects of xanthohumol alone. In this study, we examined the effects of dietary purified xanthohumol from XRHE PX, 91.9 xanthohumol on growth, diabetes, adipocytokine levels, hepatic fatty acid metabolism, and fecal excretion in KK-Ay mice, which is an animal model of obesity-diabetes.
EXPERIMENTAL PROCEDURES 2.1 Reagents
XRHE was purchased from Asama Chemical Co., Ltd., Tokyo, Japan . In this study, we purified XRHE to elucidate the biological activities of xanthohumol. All other chemicals were of analytical grade.
Puri cation of xanthohumol
We purified XRHE according to the method described by Ono et al. 11 . Around 2 g of XRHE was washed thrice with 200 mL of acetone. The filtrates were collected and concentrated to dryness. The concentrated extract was then mixed with 130 mL of ethanol and 70 mL of distilled water. Subsequently, the solution was gradually mixed with a suitable amount of 12 N NaOH until its pH reached 11. Then, the solution was mixed with 320 mL of distilled water and 19.4 g of KCl, and stirred for 30 min. After readjusting its pH to 11, the resulting mixture was subjected to filtration to remove precipitate, if any. The filtrate was collected, mixed with an appropriate amount of 25 H 2 SO 4 to reach a pH value of 8.0, and stirred very slowly for 30 min to form a yellow precipitate. This precipitate was collected by filtration, washed with 30 mL of distilled water, and lyophilized. The resultant powder was purified xanthohumol PX .
Analysis of PX
The level of phenolic compounds in PX was found to be 919.3 mg/g equivalent of xanthohumol by Folin-Ciocalteu method 12 . These compounds were analyzed using the Shimadzu LCMS 2010A series HPLC-PDA-ESI-MS system Shimadzu Co., Kyoto, Japan with YMC-Pack Pro C18 RS column 5 μm, 150 mm 2.0 mm I.D.; YMC Co., Ltd., Kyoto, Japan . Phenolic compounds were eluted using the mobile phase consisting of 0.1 v/v aqueous acetic acid phase A and 0.1 acetic acid in methanol phase B at a flow rate of 0.2 mL/min. The linear gradient of phase B was 0 for the first 1 min, increased from 0 to 100 from 1 to 55 min, and maintained at 100 from 55 to 70 min. The detector wavelength was set at 280-370 nm. The mass spectra MS were acquired in the positive ion mode for analysis of phenolic compounds. Other conditions were set as follows. Ions were scanned from 100 to 600 m/z, with a scan speed of 1,000 amu/s. Nitrogen was used as the nebulizing gas at a flow rate of 1.5 L/min. The drying gas pressure was 0.1 MPa. The HPLC max plot chromatograms of XRHE A and PX B at 280-370 nm are shown in Fig. 1 . The m/z H values of xanthohumol peak 2 were 355, 377, and 409.
Animals and diet
All animal experiments were conducted according to the guidelines provided by the Ethical Committee of Experimental Animal Care at the Meiji University approval code: IACUC 10-0008 .
KK-Ay/TaJc1 mice 3-week-old males; CLEA Japan, Inc., Tokyo, Japan were housed individually in a temperature [22] [23] [24] and light-controlled 7:00-19:00 room. After a 1-week-long acclimatization period, 13 KK-Ay/TaJc1 mice were divided into 2 groups: one group 6 mice was fed the control diet C group; 2 lard and 5 corn oil , and the other group 7 mice was fed control diet supplemented with 0.2 PX PX group . The diets were prepared according to the AIN-93G recommendations 13 ; the detailed composition of the diets is shown in Table 1 . The mice were pair-fed by measuring their daily food consumption. Body weight was measured every 7 days. After 81 days, the mice were anesthetized using diethyl ether and bled from the fundus of the eye; various tissues were then quickly excised. Plasma was prepared by centrifugation after allowing blood to clot at room temperature. These samples were kept at 80 until analysis.
Plasma and liver lipid analyses
The levels of plasma triacylglycerols, free fatty acids, total cholesterol, and high-density lipoprotein HDL cholesterol were measured using commercial kits Wako Pure Chemical Industries, Ltd., Osaka, Japan after the mice were killed. Liver lipids were extracted by the method described by Folch et al. 14 . The levels of liver triacylglycerols and cholesterol were measured according to the methods of Ide et al. 15 , Burchard et al. 16 , and Rouser et al. 17 , re- spectively.
Plasma levels of glucose, HbA1c, and insulin
The levels of plasma glucose Glucose CII-Test Wako; Wako Pure Chemical Industries, Ltd., Osaka, Japan and HbA1c Diazyme Laboratories, Inc., CA, USA were measured using kits. Plasma insulin levels were measured by using a Mercodia Mouse Insulin ELISA Kit Mercodia, Uppsala, Sweden .
Plasma adipocytokine levels
The plasma levels of adiponectin and leptin were measured using an Adiponectin mouse ELISA Kit Assaypro Co., MO, USA , and Leptin Mouse/Rat ELISA Kit AVIS-CERA BIOSCIENCE, Inc., CA, USA , respectively.
RNA extraction
Total RNA was extracted from mice liver tissue by using Sepasol-RNA I super G Nacalai Tesque, Inc., Kyoto, Japan . RNA concentration was determined by measuring the absorbance at 260 nm by using a BioSpec-nano SHI-MADZU, Co., Kyoto, Japan .
Oligonucleotide primer sequences
The primers for reverse-transcription polymerase chain reaction RT-PCR amplification of the mouse sterol regulatory element-binding protein 1c SREBP1c , fatty acid synthase FAS , glucose-6-phosphate dehydrogenase G6PDH , malic enzyme ME , peroxisome proliferator-activated receptor alpha PPARα , acyl-CoA oxidase ACOX , and carnitine palmitoyltransferase II CPTII gene were designed using Primer3Plus software http://www.bioinformatics.nl/cgi-bin/primer3plus.cgi . The primers, synthesized by Operon Biotechnologies Tokyo, Japan , were designed to flank known or putative introns of this gene, thereby preventing the amplification of any contaminating genomic DNA. The primer sequences were as follows: SREBP1c Gene ID: 78968 , forward 5 -GGAGCCATG-GATTGCACATT-3 and reverse 5 -AGGAAGGCTTC-CAGAGAGGA-3 ; FAS Gene ID: 50671 , forward 5 -TC-G A G A C A C AT C G T T T G A G C -3 a n d r e v e r s e 5 -CCCAGAGGGTGGTTGTTAGA-3 ; G6PDH Gene ID: 14380 , forward 5 -CTGTCGAACCACATCTCCTCTCT-3 and reverse 5 -GACCATCTCTTTGCCCAGGTAGT-3 ; ME Gene ID: 17436 , forward 5 -TGCATGGCCAGAGGAT-GTC-3 and reverse 5 -CATTACAGCCAAGGTCTCCCA-3 ; PPARα Gene ID: 25747 , forward 5 -GTGTGATCGAAGCT-GCAAGA-3 and reverse 5 -GCCAGAGATTTGAGGTCT-GC-3 ; ACOX Gene ID: 50681 , forward 5 -TGCCTTTGTT-G T C C C T A T C C -3 a n d r e v e r s e 5 -GGTCCCATACGTCAGCTTGT-3 ; CPTII Gene ID: 25413 , forward 5 -TCCTCGATCAAGATGGGAAC-3 and reverse 5 -GATCCTTCATCGGGAAGTCA-3 ; and glyceraldehyde 3-phosphate dehydrogenase GAPDH, Gene ID: 24383 , forward 5 -CTCATGACCACAGTCCATGC-3 and reverse 5 -TTCAGCTCTGGGATGACCTT-3 , which was used as a control.
Real-time quantitative polymerase chain reaction
One microgram of RNA was incubated at 65 for 5 min, and then quickly cooled on ice. Reverse transcription of RNA was performed using a ReverTra Ace qPCR RT Master Mix with gDNA Remover Toyobo Co., Ltd., Osaka, Japan and by heating the sample to 37 for 15 min, followed by heating at 98 for 5 min. An aliquot of the generated cDNA samples was mixed with 5 μL of THUNDERBIRD SYBR qPCR MIX Toyobo Co., Ltd., Osaka, Japan in the presence of 0.3 μmol of each of the forward and reverse primers for GAPDH and SREBP1c. This reaction mix was then subjected to the following cycling conditions in a Chromo 4 Sequence Detection System Bio-Rad Laboratories, Inc., Hercules, CA, USA : 1 cycle at 95 for 1 min, followed by 40 cycles each of 95 for 15 s and 58.5 for 1 min. The results fold-changes were expressed as relative folds by comparing the amount of RNA of the target gene to that of GAPDH as an internal control, as determined by the equation 2 -C t target C t GAPDH .
Fatty acid and carbohydrate levels in feces
Fatty acids in feces were extracted by the method described by Jeejeebhoy et al. 18 , and analyzed using the Shimadzu gas chromatograph GC-14B Shimadzu Co., Kyoto, Japan with ZB-WAX column 0.25 mm I.D. 30 m; Phenomenex, CA, United States . Carbohydrates in feces were extracted by the method described by Okuma et al. 19 . Fecal glucose levels were measured using a commercial kit Glucose CII-Test Wako; Wako Pure Chemical Industries, Ltd., Osaka, Japan .
Inhibition of lipase or α-amylase activity by PX in vitro
The inhibition of lipase activity by PX was analyzed according to the method of Kurihara et al. 20 . After the hydrolysis of triolein with or without PX, the level of free fatty acids was measured using a commercial kit NFEF C-test Wako; Wako Pure Chemical Industries, Ltd., Osaka, Japan . The inhibition of α-amylase activity by PX was analyzed according to the method of Yoshikawa et al. 21 . The concentration of remainder starch, after hydrolysis of soluble starch, was also measured by iodo-starch reaction.
Statistical analysis
The data are expressed as the mean standard deviation SD . The data were analyzed statistically using the Student s t-test to evaluate significant differences between the values of the 2 groups.
RESULTS

Effects of dietary PX on growth parameters
Body weight was not significantly different between the 2 groups from days 0 to 81. There were no significant differences in the final body weight, waist size, and liver weight at 81 days between the 2 groups Table 2 . Cecal weight was significantly higher in the PX group, compared to the C group. However, the weight of epididymal, perirenal, or mesenteric white adipose tissues was significantly lower in the PX group than in the C group. Thus, the total weight of white adipose tissues was significantly lower in the PX group than in the C group.
Effects of dietary PX on plasma and liver lipid levels
Plasma triacylglycerol, free fatty acids, total cholesterol, and HDL cholesterol levels were not significantly different between the 2 groups Table 3 .
Liver triacylglycerol level did not significantly different between the groups. However, total liver cholesterol level was significantly lower in the PX group, compared to that in the C group.
Effects of dietary PX on fasting blood glucose,
HbA1c, and insulin levels Plasma fasting blood glucose, HbA1c, and insulin levels were not significantly different between the 2 groups Fig.  2 . However, HbA1c levels in the PX group tended to be lower than in the C group p 0.07 . Furthermore, the fasting plasma glucose and insulin levels in the PX group were lower, compared to that in the C group.
Effects of dietary PX on plasma adiponectin and
leptin levels Plasma adiponectin level was not significantly different between the 2 groups. However, plasma leptin level was significantly lower in the PX group than in the C group Fig.  3 .
Effects of dietary PX on mRNA expression of SREB-
P1c and fatty acid synthesis enzymes in the liver The hepatic mRNA expression of SREBP1c was significantly lower in the PX group than in the C group Fig. 4 . Moreover, mRNA expression of FAS and ME was lower in the PX group than in the C group, although the former was not significant p 0.05 .
Effects of dietary PX on mRNA expression of PPARα
and fatty acid β-oxidation enzymes in the liver The hepatic mRNA expression of PPARα was significantly higher in the PX group than in the C group Fig. 5 . The mRNA expression of ACOX and CPT II was higher in the Table 2 Effect of dietary PX on growth parameters. Table 3 Effect of dietary PX on plasma and liver lipid levels.
PX group.
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Effects of dietary PX on fecal excretion of fatty acid or carbohydrates Fecal weight was not significantly different between the 2 groups Fig. 6 . However, fecal levels of fatty acids and carbohydrate were significantly higher in the PX group than in the C group.
Inhibitory action of PX on lipase or α-amylase activity
Lipase activity was inhibited by PX at 0.25-2.5 mg/mL Fig. 7 ; however, it was not dose-dependent. Contrary to this observation, α-amylase activity was inhibited in a dose-dependent manner, and the half-maximal inhibitory concentration of PX was 10 mg/mL.
DISCUSSION
Increasing cases of obesity due to overnutrition or lack of exercise have become a serious social problem in developed countries because obesity is closely related to the development of various lifestyle diseases 22, 23 . Therefore, the anti-obesity effects of some food ingredients have been attracting additional attention. The anti-obesity effect of tea catechins, including --epigallocatechin-3-gallate, is widely accepted 24 ; it is a government-approved food for specified healthcare-related use in Japan. Many other polyphenols play regulatory roles in lipid metabolism. For example, quercetin reduced plasma and liver lipid levels in C57BL/6JOlaHsd mice by regulating lipid metabolism 25 . Procyanidins also exert hypolipidemic effects in various animal models 5, 26 .
In this study, we focused on the anti-obesity effects of polyphenols obtained from hop extract. In another recent study, we observed that dietary XRHE strongly suppressed body weight gain and increase in liver weight and triacylglycerol levels in the plasma and liver, through the regulation of hepatic fatty acid metabolism and inhibition of intestinal fat absorption in Wistar male rats fed a high-fat diet 7 . However, it was not clear whether those effects were exerted by xanthohumol alone because XRHE has 82 unknown non-flavonoid compounds. Here, we studied the anti-obesity effects of PX containing 91.9 xanthohumol in order to elucidate the action of xanthohumol alone.
We observed that dietary PX significantly inhibited the Fig. 2 Effect of dietary PX on fasting blood glucose, HbA1c, and insulin levels. Data are presented as the mean SD of the data for 6 or 7 mice in each group. Abbreviations are the same as in Table 1 . Table 1 .
weight gain of epididymal, perirenal, and mesenteric white adipose tissues, although the final body weight did not change between the 2 groups. These observations were different from those of the previous study using XRHE in rats fed a high-fat diet 7 . This discrepancy can be attributed to the differences in species or dietary conditions. However, we expect xanthohumol to inhibit the increase in adipose tissue mass. Further studies are necessary to clarify this discrepancy. Dietary PX reduced the levels of fasting blood glucose and insulin in male KK-Ay mice, although not significantly. HOMA-IR level also tended to be lower in the PX group 21.9 8.08 , compared to the C group 42. 28 8.65 . We found that dietary hop pomace polyphenols significantly reduced the fasting blood glucose and HbA1c levels in Otsuka Long Evans Tokushima Fatty OLETF rats at 40 days 5 . These effects may be exerted by the inhibition of carbohydrate digestion because PX inhibited α-amylase activity and promoted carbohydrate excretion into feces as described later. Some polyphenolics inhibited carbohydrate digestion 27, 28 . Dietary PX may show anti-hyperglycemic effects by inhibiting glucose absorption, exerted by the inhibition of carbohydrate-hydrolyzing enzymes. Liver is an essential organ that plays a key role in the metabolism of fatty acids, cholesterol, and carbohydrates. Hepatic fatty acid level is mainly regulated by fatty acid synthesis and fatty acid β-oxidation.
However, the triacylglycerol levels in the plasma and liver are not modulated by dietary PX. These observations differ from those of a previous study involving rats fed a Data are presented as the mean SD of the data for 6 or 7 mice in each group. *Significantly different from C group at p 0.05 Student s t-test . SREBP1c, sterol regulatory element-binding protein1c; FAS, fatty acid synthase; G6PDH, glucose-6-phosphate dehydrogenase; ME, malic enzyme. Other abbreviations are the same in Table 1 .
high-fat diet containing XRHE 7 . We inferred that the present results might be affected by the non-fasting condition or differences among species. Dietary PX suppressed FAS and ME mRNA expression through reduction of SREBP1c mRNA expression. These data agreed with those from a previous study involving XRHE-fed rats. Other researchers reported the anti-obesity and anti-diabetes effect of xanthohumol. For example, Miyata et al. reported that dietary xanthohumol reduced body weight, liver weight, white adipose tissue weight, and triacylglycerol levels in the liver through the regulation of hepatic SREBP1c mRNA expression and promotion of fecal excretion of triacylglyc-erols in C57BL/6J mice fed a high-fat diet 9 . LeeCole et al.
reported that xanthohumol lowered the body weight and fasting plasma glucose levels in obese male Zucker rats 29 . Prakash et al. reported that dietary xanthohumol markedly reduced plasma cholesterol levels and hepatic triacylglycerol and cholesterol levels by suppressing hepatic lipid metabolism via activation of AMP-activated protein kinase in ApoE-deficient mice 30 . Thus, xanthohumol and its metabolites exert regulatory effects on hepatic lipid metabolism.
In the present study, we found that dietary PX significantly increased hepatic fatty acid β-oxidation activities, involving ACOX and CPTII, by upregulating hepatic PPARα Data are presented as the mean SD of the data for 6 or 7 mice in each group. *Significantly different from C group at p 0.05 Student s t-test . PPAR, peroxisome proliferator-activated receptor alpha; ACOX, acyl-CoA oxidase; CPT II, carnitine palmitoyltransferase II. Other abbreviations are the same in Table 1 . Table 1 .
mRNA expression. The effect of XRHE on fatty acid β-oxidation was not clarified in previous studies. Dietary xanthohumol may regulate fatty acid metabolism by promoting hepatic fatty acid β-oxidation in addition to suppressing fatty acid synthesis, although this needs to be verified in other animal models. Hepatic cholesterol levels were lowered by dietary PX. These results are consistent with those of a previous study using XRHE 7 . Other polyphenols also exerted hypocholesterolemic effect in various animal model 31, 32 . Metabolites from xanthohumol such as 8-prenylnaringenin may modulate hepatic cholesterol metabolism because of estrogen activity 33 .
Adipocytokines are endocrine factors secreted by adipocytes; they play important roles in homeostasis maintenance by being involved in carbohydrate and lipid metabolism 34 . Leptin, mainly produced by the white adipose tissue, regulates energy level, food intake, and various inflammatory mediators. We observed that dietary PX reduced plasma leptin levels, along with a decrease in white adipose tissue mass, in KK-Ay mice. It tended to increase plasma adiponectin levels in Wistar rats in a previous study 7 , although this effect was not observed in the present study. Therefore, dietary PX may improve plasma adipocytokine levels, especially leptin, by decreasing visceral fat weight in mice.
The fecal fatty acid and carbohydrate levels in the PX group significantly increased, as observed in case of XRHE consumption. PX inhibited the activity of a pancreatic lipase and α-amylase in our in vitro experiment IC 50 of PX on α-amylase was 10 mg/mL . Thus, dietary PX may exert anti-obesity effects through the suppression of lipid and carbohydrate absorption from the small intestine by inhibiting pancreatic lipase and α-amylase activities. These effects may be related to the above-mentioned results.
Cecal weight significantly increased by dietary PX. The final body weight without cecal weight tended to be lower in the PX group 42.2 2.8 g than in the C group 43.6 3.4 g . Moreover, the total WAT weight was significantly lower in the PX group 8.08 0.47 g/100 g body weight than in the C group 6.1 0.2 g body weight . The effect of shortchain fatty acids SCFAs will be examined in the next study because intestinal bacterial flora may be altered by the antibiotic activity of PX and because SCFA may affect lipid metabolism.
Xanthohumol is a major prenylated flavonoid chalcone found in the hop plant. Approximately 1000 prenylated flavonoids have been identified from plants. The hydrophobic prenyl chain can affect cellular uptake and biological functions by improving the affinity for biological membranes 35 . Chalcones and prenylated flavonoids were reported to exert anti-obesity effects, except for the physiological effects such as anti-inflammatory and anti-diabetes activities. For example, phlorizin, one of the dihydroxychalcones typically contained in apples, ameliorated lipid metabolism and plasma glucose levels in streptozotocin-induced diabetic rats 36 . In addition, licochalcone A, a major prenylated flavonoid constituent of the Glycyrrhiza plant, prevented adipocyte differentiation and lipogenesis through the suppression of PPARγ and SREBP1 in ICR mice and 3T3-L1 cells 37 . Moreover, 4-hydroxyderricin 4-HD and xanthoangelol XAG , the major prenylated chalcones present in Data are presented as the mean SD of 3 analyses.
Ashitaba, prevented adiposity by modulating lipid metabolism via phosphorylation of AMP-activated protein kinase in the adipose tissue and liver 38 . Moreover, 8-prenyl quercetin, 4-HD, and XAG were found to be absorbed and distributed to various tissues such as the liver and white adipose tissue, in recent studies 39 . Therefore, we inferred that xanthohumol, a prenylated chalcone, may ameliorate lipid and glucose metabolism by affecting various tissues, like other chalcones and prenylated flavonoids. This study was performed to elucidate the anti-obesity effects of xanthohumol alone, by using PX. We observed that dietary PX exerted anti-obesity effects by regulating lipid metabolism and inhibiting intestinal fat absorption in KK-Ay mice; this was observed in previous experiments with XRHE-fed rats too. PX contains 91.9 xanthohumol. Thus, we suggested that xanthohumol may exert antiobesity effects. However, dietary PX did not exert significantly different effects on the plasma lipid and liver triacylglycerol levels in KK-Ay mice, which is an animal model of obesity-diabetes. On the other hand, these parameters changed in a previous study involving rats. This discrepancy can be attributed to species difference and dietary conditions. Dietary PX significantly lowered hepatic cholesterol levels. However, because few studies focused on xanthohumol-induced changes in cholesterol metabolism, little is known about the effect of xanthohumol on cholesterol metabolism. In future studies, we will examine in detail the effects and mechanism of the cholesterol-lowering effect of PX by using healthy mice.
CONCLUSION
We observed that dietary PX inhibited the increase in visceral fat weight in KK-Ay mice by regulating hepatic fatty acid metabolism and leptin secretion from adipocytes. Dietary PX also promoted fecal excretion of fatty acids and carbohydrates. Thus, it can be said that xanthohumol alone exerts anti-obesity effects because PX contains 91.9 xanthohumol.
